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RESEARCH ARTICLE
Interaction among Saccharomyces cerevisiae pheromone
receptors during endocytosis
Chien-I Chang*, Kimberly A. Schandel` and Duane D. Jenness§
ABSTRACT
This study investigates endocytosis of Saccharomyces cerevisiae
a-factor receptor and the role that receptor oligomerization plays in
this process. a-factor receptor contains signal sequences in the
cytoplasmic C-terminal domain that are essential for ligand-
mediated endocytosis. In an endocytosis complementation assay,
we found that oligomeric complexes of the receptor undergo ligand-
mediated endocytosis when the a-factor binding site and the
endocytosis signal sequences are located in different receptors.
Both in vitro and in vivo assays suggested that ligand-induced
conformational changes in one Ste2 subunit do not affect
neighboring subunits. Therefore, recognition of the endocytosis
signal sequence and recognition of the ligand-induced
conformational change are likely to be two independent events.
KEY WORDS: G-protein coupled receptors, Receptor oligomers,
Ligand-mediated endocytosis
INTRODUCTION
G protein-coupled receptors (GPCRs) are cell-surface receptors
that are present in all eukaryotic organisms. They mediate cellular
responses to a wide variety of extracellular ligands and conditions
(e.g. hormones, neurotransmitters, odorants and light), and their
activity is regulated by covalent modification, by interacting
proteins and by membrane protein trafficking (Jean-Alphonse
and Hanyaloglu, 2011; Magalhaes et al., 2012). Each receptor
contains seven transmembrane-spanning domains, and individual
receptors are assembled into multimeric complexes (Salon et al.,
2011). Upon ligand binding, the receptor undergoes a
conformational change that results in receptor endocytosis in
addition to the activation of the heterotrimeric G protein and the
consequent signal transduction events. The ways in which signal
transduction and membrane protein traffic are related to the
oligomeric state of the receptors remain poorly understood.
The a-factor receptor encoded by the STE2 gene of
Saccharomyces cerevisiae is a GPCR that mediates the
responsiveness of haploid cells of the a mating type to the a-
factor peptide produced by haploid cells of the a mating type. The
receptors are endocytosed constitutively, and the endocytosis rate
increases roughly ten fold upon a-factor binding (Jenness and
Spatrick, 1986; Schandel and Jenness, 1994). Endocytosis is
associated with phosphorylation and ubiquitination of a specific
endocytosis signal sequence located in the cytoplasmic C-
terminal domain of the receptor (Hicke et al., 1998). Both
physiological and biochemical evidence indicates that a-factor
receptors form homomultimers in the plasma membrane: a-factor
induced internalization of receptor sites is more rapid than
internalization of a-factor itself (Jenness and Spatrick, 1986),
endocytosis-defective receptors and endocytosis-proficient
receptors are co-internalized (Overton and Blumer, 2000;
Yesilaltay and Jenness, 2000), differentially-tagged receptors
are co-immunoprecipitated (Yesilaltay and Jenness, 2000),
fluorescence resonance energy transfer (FRET) occurs between
receptors tagged with different fluorescent proteins (Overton and
Blumer, 2000), and mutant receptors containing cysteine residue
substitutions form inter-protein disulfide cross-links (Wang and
Konopka, 2009; Uddin et al., 2012). Recent FRET measurements
using a spectrally resolved two-photon microscope are consistent
with a-factor receptor multimers containing at least four
protomeric units arranged in a parallelogram-shaped tetramer
(Raicu et al., 2009). Contact points between protomers have been
inferred using FRET measurements of cells expressing receptor
fragments (Overton and Blumer, 2002; Overton et al., 2003) and
using cysteine–disulfide cross-linking (Wang and Konopka,
2009; Uddin et al., 2012; Umanah et al., 2011), implicating the
first and fourth transmembrane spanning domains and
transmembrane domains flanking the third intracellular loop.
Multiple contact sites between receptors are consistent with the
higher-order multimeric structures indicated by spectrally
resolved two-photon microscopy (Raicu et al., 2009). Thus far,
no communication between protomers within a-factor receptor
multimers has been identified in that a-factor binding is non-
cooperative (Jenness et al., 1986) and a-factor-binding-defective
receptors are unable to complement signaling-defective receptor
mutants in vivo (Chinault et al., 2004).
This study investigates cooperation among a-factor receptor
protomers during endocytosis. Specifically, we ask whether the
binding of a-factor to one protomer can utilize the endocytosis
signal sequence located in a different protomer of the multimeric
complex to stimulate ligand-induced endocytosis. This question
pertains to the ability of a-factor-induced conformational changes
to spread among the protomers within the complex and to the
possibility that the endocytosis signal sequence requires a ligand-
induced change in order to interact with the endocytic apparatus.
We found that oligomeric complexes of the receptor undergo
ligand-mediated endocytosis when the a-factor binding site and the
endocytosis signal sequences are located in different protomers,
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indicating that individual receptors cooperate to provide different
receptor functions in trans. However, three different assays showed
that binding of a-factor to one protomer does not influence the
conformational state of neighboring protomers, suggesting that
ligand-induced conformational changes and recognition of the
endocytosis signal are independent events associated with different
regions of the receptor. As a metaphor, a-factor receptors are
train passengers that travel as a group. Even without a ticket
(endocytosis signal sequence), one member of the group can
recognize the train (bind a-factor), board the train (interact with the
endocytic machinery) and help his companions board (using
subunit interactions). At some point, the conductor will check that
at least one member of the group possesses the group’s ticket
(endocytosis signal sequence) before the train leaves the station
(move from the plasma membrane to the vacuole).
RESULTS
Complementation between two mutant Ste2 subunits during
endocytosis
Our laboratory previously has shown that when wild-type a-
factor receptors undergo ligand-mediated endocytosis, they cause
a concomitant internalization of co-expressed endocytosis-
defective receptors (Yesilaltay and Jenness, 2000). The
defective receptors either lacked the a-factor binding site (Ste2-
S184R) or lacked the endocytosis-signal sequences located in the
C-terminal cytoplasmic domain of the receptor (Ste2-T326). The
results were taken as evidence for endocytosis of homo-
oligomeric receptor complexes. In the present study, we have
extended this approach to investigate whether receptor-mediated
endocytosis requires that the a-factor binding site and the
endocytosis signal reside in the same receptor protein or
whether the two elements can promote endocytosis even when
they reside in different receptors of the oligomeric complex. We
used the Ste2-F204S mutant instead of the Ste2-S184R to block
a-factor binding (Fig. 1) because Ste2-F204S leads to a more
pronounced defect in the a-factor response (Dosil et al., 2000).
Ste2-T326 mutant receptors (Konopka et al., 1988) are truncated
at residue 326 in the cytoplasmic C-terminal domain, and they
lack the SINNDAKSS endocytosis signal sequence (Hicke et al.,
1998; Rohrer et al., 1993). Green fluorescent protein (GFP) was
fused to the C-terminus of the truncated Ste2-T326 receptors and
to the truncated binding-defective Ste2-F204S,T326 receptors
(Ste2-T326-GFP and Ste2-F204S,T326-GFP, respectively) in
order to monitor their position by fluorescence microscopy
when they are co-expressed with full-length untagged receptors
(wild-type Ste2 or binding-defective Ste2-F204S). Our previous
results (Yesilaltay and Jenness, 2000) showed that Ste2-T326-
GFP is not subject to a-factor-induced internalization in absence
of co-expressed receptors. In the present study, cells co-
expressing two binding-defective receptors (Ste2-F204S,T326-
GFP and Ste2-F204S) served as a negative control (Fig. 2, top
row). In the absence and presence of a-factor, cells exhibited
similar fluorescence both at the plasma membrane and in the
vacuole. Fluorescence in the vacuole reflects the slow basal rate
of constitutive endocytosis; free GFP remains intact in the
vacuole after the Ste2-GFP fusion proteins have been
endocytosed and the Ste2 portion of the fusion proteins has
been degraded (Li et al., 1999). Yeast cells co-expressing Ste2-
T326-GFP and wild-type Ste2 served as a positive control (Fig. 2,
second row). Yeast cells co-expressing tagged truncated Ste2-
F204S,T326-GFP and wild-type Ste2 served as a second positive
control (Fig. 2, third row). In the absence of a-factor, both
positive control strains showed very similar fluorescence
localization. In the presence of a-factor, unlike the negative
Fig. 1. Positions of selected sites in the receptor structure. Schematic
representation of the a-factor receptor shows the seven transmembrane
domains (boxes) embedded in the cellular membrane (stippled) and joined
by the extracellular N-terminal domain, the cytoplasmic C-terminal domain,
the three extra-cellular loops and the three cytoplasmic loops. Ste2-S184R
and Ste2-F204S receptors fail to bind a-factor (Dosil et al., 2000; Yesilaltay
and Jenness, 2000). Ste2-L236H receptors bind a-factor and undergo ligand-
mediated endocytosis, but they fail to generate intracellular signals that lead
to cell division arrest and transcriptional activation (Schandel and Jenness,
1994). Ste2-T326 receptors are truncated at residue 326 and fail to undergo
ligand-mediated endocytosis (Konopka et al., 1988; Schandel and Jenness,
1994); they lack the SINNDAKSS endocytosis signal sequence (Rohrer
et al., 1993).
Fig. 2. Ligand-induced internalization of GFP-tagged endocytosis-
defective receptors depends on presence of full-length binding-
defective receptors Ste2-F204S or full-length wild-type receptors Ste2.
Cultures were treated with cycloheximide and a-factor for 15 minutes at
30˚C. GFP fluorescence images and Nomarski images (DIC) are indicated
below each column; first two columns are cultures lacking a-factor; the last
two columns are cultures treated with a-factor. First row, cells expressed both
untagged Ste2-F204S and Ste2-F204S,T326-GFP (strain DJ485-1
containing plasmid pDJ651). Second row, cells expressed both untagged
Ste2 and Ste2-F204S,T326-GFP (strain DJ484-1 containing plasmid
pDJ651). Third row, cells expressed both untagged Ste2 and Ste2-T326-
GFP (strain DJ484-1 containing plasmid pDJ469). Bottom row, cells
expressed both untagged Ste2-F204S and Ste2-T326-GFP (strain DJ485-1
containing plasmid pDJ469). Scale bar: 2 mm.
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control strain, both strains showed that the fluorescence on the
plasma membrane had been reduced significantly and that the
fluorescence mostly appeared in internal punctate structures.
Interestingly, cells co-expressing both truncated Ste2-T326-
GFP and the full-length binding-defective mutant Ste2-F204S
(Fig. 2, bottom row) showed a pattern that was indistinguishable
from the positive controls, indicating ligand-mediated
endocytosis occurs when the a-factor binding site and the
endocytosis signal reside in separate receptors. The GFP was
significantly decreased on the plasma membrane and mostly
appeared in the internal punctate structures when a-factor was
present. We analyzed the data quantitatively in Table 1. For
negative control cells expressing both Ste2-F204S,T326-GFP and
full-length Ste2-F204S, a-factor did not induce the appearance of
fluorescence foci, consistent with the inability of either receptor
to bind a-factor. In contrast, over 80% of cells co-expressing both
Ste2-T326-GFP and Ste2-F204S showed one or more foci after a-
factor treatment. Similar results were observed for both of the
positive controls (Ste2 expressed as Ste2-F204S,T326-GFP and
Ste2-F204S expressed as Ste2-F204S,T326-GFP).
These endocytosis complementation results indicated that two
mutant subunits in a receptor complex can cooperate during
endocytosis if one subunit provides the a-factor binding site
(Ste2-T326-GFP) and another provides the endocytosis signal
sequence (Ste2-F204S). We considered two models consistent
with these results. In one model, the ligand-induced change in one
subunit is communicated to the neighboring subunit, activating its
endocytosis signal sequence. In the other model, the endocytosis
machinery recognizes the ligand-induced conformational change
and the endocytosis signal sequence independently. In the first
model, the endocytosis signal plays an active role in ligand-
induced endocytosis, whereas in the second model the
endocytosis signal plays a passive role. In order to distinguish
between these two models, we tested whether a-factor binding to
one receptor subunit influences the conformational state of other
subunits in the receptor complex.
Conformational changes among co-expressed wild-type and
mutant a-factor receptors
We employed three methods to detect a-factor induced
conformational changes in binding-defective receptors when
they are co-expressed with binding-competent receptors. The a-
factor-induced conformational changes can be detected in vitro
by subjecting purified plasma membranes to limited trypsin
digestion in the presence and absence of a-factor (Büküşoğlu and
Jenness, 1996). The influence of a-factor on the rate of specific
cleavages can be monitored by western blotting. The third
intracellular loop has been found to be more accessible to trypsin
cleavage in the ligand occupied receptors, whereas a site near the
SINNDAKSS endocytosis signal in the C-terminal domain of
Ste2 is more accessible to trypsin cleavage in the unoccupied
receptors (Büküşoğlu and Jenness, 1996). Differences in trypsin
cleavage rates between occupied and unoccupied receptors reflect
ligand-mediated changes in both the third intracellular loop and in
the C-terminal domain. Recent evidence suggests that changes in
accessibility of the third intracellular loop are likely to reflect
movements in the flanking transmembrane domains (Umanah et
al., 2011).
In the present study, the trypsin accessibility assay was
performed essentially as described previously (Büküşoğlu and
Jenness, 1996) except that receptors contained either the HA or the
T7 epitope fused at the N-terminus and purified plasma membranes
were assayed instead of crude membrane preparations. Plasma
membranes were digested with trypsin in the presence and absence
of 1028 M a-factor. At various time points, samples were
withdrawn, treated with endoglycosidase H to remove N-linked
carbohydrates and then resolved by SDS-PAGE. Cleavage products
containing the epitope tag were detected by western blotting. At the
initial time point, undigested membrane preparations contained two
electrophoretic species corresponding to full-length receptor
(approximately 43 kDa) and a smaller fragment (35 kDa) that
apparently resulted from cleavage during membrane preparation
(Fig. 3C,D). Three trypsin cleavage products were detected during
the time course of the reaction. The F2 cleavage product results
from cleavage in the C-terminal cytoplasmic domain at a site near
the SINNDAKSS endocytosis signal, and the F1 fragment results
from cleavage at a distal site in the C-terminal cytoplasmic domain.
The F3 fragment results from cleavage in the third intracellular loop
of the receptor. As shown in Fig. 3C,D, and consistent with our
previous observations (Büküşoğlu and Jenness, 1996), the rate of
cleavage at that site near the SINNDAKSS sequence was reduced
when a-factor was present as judged by the slower appearance of
the F2 fragment. The rate of cleavage in the third intracellular loop
of the receptor was increased when a-factor was present as judged
by faster accumulation of the F3 fragment. Similar results were
obtained when the membranes contained receptors that were
defective for both of the N-linked glycosylation sites at positions
N25 and N32 in wild-type receptors (Fig. 4A). As previously
reported (Mentesana and Konopka, 2001), full-length
unglycosylated receptor appears as a doublet band on SDS-PAGE
due to a greater level of phosphorylation. It has also been shown
that mutations affecting the two sites near the receptor N-
terminus of Ste2 (N25Q and N32Q) eliminated detectable N-
glycosylation of receptors, and the non-glycosylated receptors
retain normal function and sub-cellular location (Mentesana and
Konopka, 2001).
Table 1. Quantitative summary of fluorescent foci induced by
a-factor in the endocytosis complementation assay
Percentage of cellsa
Ste2 forms expressedb a-factor n>1 n>3
Ste2-F204S and Ste2-F204S-T326-GFP 2 362 0
Ste2-F204S and Ste2-F204S-T326-GFP + 563 0
Ste2 and Ste2-F204S-T326-GFP 2 463 161
Ste2 and Ste2-F204S-T326-GFP + 7765 1666
Ste2 and Ste2-T326-GFP 2 564 161
Ste2 and Ste2-T326-GFP + 8565 1865
Ste2-F204S and Ste2-T326-GFP 2 462 161
Ste2-F204S and Ste2-T326-GFP + 8264 1863
aFluorescent foci were counted based on GFP images of cells. Cells were
treated with cycloheximide for 5 minutes and then cultured for 15 minutes in
the absence or presence of a-factor. Percentage of cells with one or more
fluorescent foci (n>1) and the percentage of cells with three or more
fluorescent foci (n>3) are indicated on the last two columns. More than 100
cells were examined for each entry. Each entry has been performed twice
from two independent experiments, and the error indicates standard
deviation.
bThe forms of Ste2 expressing in each strain are shown. Strains used are
DJ482-1 containing plasmid pDJ651 (rows 1, 2), DJ484-1 containing plasmid
pDJ651 (rows 3, 4), DJ484-1 containing plasmid pDJ469 (rows 5, 6) and
DJ482-1 containing plasmid pDJ469 (rows 7, 8).
Untagged Ste2 or Ste2-F204S is encoded by a chromosomal allele and
GFP-tagged endocytosis-defective Ste2-T326-GFP or Ste2-F204S,T326-
GFP is encoded by the low copy number plasmid.
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Ste2-F204S exhibits a strong defect in a-factor binding
(KD.10
26 M). The mutant receptors show normal subcellular
localization, and they do not alter the subcellular localization of
co-expressed wild-type Ste2 receptors (Dosil et al., 2000). For the
Ste2-F204S mutant to be useful, it must be capable of attaining
the conformational state that is induced by a-factor. Consistent
with this property, Dosil et al. found that the Ste2-F204S mutant
cells were responsive to high a-factor concentration in cell
division arrest (halo) assay and in a-factor induced transcription
assays (Dosil et al., 2000). At high a-factor concentration
(561026 M), a significant portion of the Ste2-F204S mutant
receptors is expected to be ligand-occupied. We found that this
ligand concentration caused trypsin to cleave the Ste2-F204S
mutant receptors in manner that was qualitatively similar to its
effect on wild-type receptors. After two minutes in trypsin at
561026 M a-factor, both the Ste2-F204S mutant and the control
membrane preparation showed a reduced accumulation of the F2
cleaved product relative to the F1 cleavage products; and after
20 minutes, both membrane preparations showed increased
accumulation of the F3 cleavage product relative to F2
(compare Fig. 3E with Fig. 3F). These results indicate that
Ste2-F204S receptors undergo ligand-induced conformational
changes when the ligand-binding site is occupied at 561026 M a-
factor. At a-factor concentration of 1026 M or less, conformational
changes in Ste2-F204S were not detected. The a-factor binding
that causes a conformational change that begins to appear at
561026 M (i.e. below the KD) would affect fewer than one in 500
receptors at 1028 M a-factor.
When plasma membranes from cells expressing both wild-type
receptors and T7-tagged Ste2-F204S mutant receptors were
subjected to the limited trypsin digestion assay, binding of a-
factor to the wild-type receptors was unable to influence cleavage
rates of the trypsin sites in the mutant receptors. Fig. 3 compares
results obtained with two different plasma membrane
Fig. 3. Limited trypsin digestion time course for co-
expressed wild-type and T7-Ste2-F204S mutant
receptors. Purified plasma membranes were incubated
with trypsin in the absence (2) or presence (+) of
1028 M a-factor (aF). Resulting cleavage products were
analyzed by SDS-PAGE and western blotting. Digestion
reaction I contained membranes from cells expressing
T7-Ste2-F204S and no wild-type Ste2 (strain DJ213-7-3
containing plasmid pDJ655). Digestion reaction II
contained membranes from cells expressing T7-Ste2-
F204S and over-produced wild-type Ste2 (strain DJ484-
1 containing plasmid pDJ655). Membranes from cells
expressing HA-Ste2 (strain DJ213-6-3::pDJ281) were
added to both digestion reactions as an internal control.
(A) Digestion reaction I probed with anti-T7 antiserum.
(B) Digestion reaction II probed with anti-T7 antiserum.
(C) Digestion reaction I probed with anti-HA antiserum.
(D) Digestion reaction II probed with anti-HA antiserum.
(E) Control experiment showing that Ste2-F204S
receptors (T7-Ste2-F204S,N25Q,N32Q) undergo
qualitatively similar ligand-induced changes when the
sites are partially occupied at 561026 M a-factor (strain
DJ213-7-1 containing plasmid pDJ657). (F) Binding
proficient receptors (T7-Ste2-N25Q,N32Q) with
561026 M a-factor (strain DJ213-7-1 containing
plasmid pDJ656).
Fig. 4. Reciprocal tests for interactions between mutant and wild-type
receptors in the trypsin digestion assay. Membranes were incubated with
trypsin in the absence (2) or presence (+) of 1028 M a-factor (aF). Antiserum
was against the T7 epitope-tag fused to the N-terminus of the receptors. Two
major glycosylation sites (position 25 and 32) on T7-tagged Ste2 have been
removed by genetic manipulation for experimental convenience.
(A) Membranes were from cells expressing untagged wild-type Ste2 and
T7-tagged Ste2-N25Q,N32Q (strain DJ213-7-3 containing plasmid pDJ656).
(B) Membranes were from cells expressing untagged wild-type Ste2 and
T7-tagged Ste2-F204S-N25Q,N32Q (strain DJ484-1containing plasmid
pDJ657). (C) Membranes were from cells expressing T7-tagged Ste2-
F204S-N25Q,N32Q (strain DJ213-7-3 containing plasmid pDJ657).
(D) Membranes were from cells expressing untagged Ste2-F204S and
T7-tagged Ste2-N25Q,N32Q (strain DJ482-1 containing plasmid pDJ656).
The resulting cleavage products were analyzed by SDS-PAGE and
immunoblotting using anti-T7 antiserum. Three major cleavage products (F1,
F2 and F3) are indicated at the right. Time points for treatment of trypsin are
indicated on the bottom. All untagged receptors were synthesized under the
direction of the GPD transcriptional promoter.
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preparations. One preparation was from cells that expressed a
normal level of the T7-tagged Ste2-F204S receptors (Fig. 3A,C),
and the other preparation was from cells that expressed a normal
level of T7-tagged Ste2-F204S receptors and over-expressed
wild-type receptors (Fig. 3B,D). As a positive internal control,
plasma membranes from cells expressing HA-tagged wild-type
receptors were added to both preparations. Each of the two
preparations was digested with trypsin in the presence and
absence of 1028 M a-factor. This concentration of a-factor
induced conformational changes in wild-type Ste2 but did not
induce conformational changes in Ste2-F204S. Membranes
containing T7-tagged Ste2-F204S alone (Fig. 3A) and
membranes containing both T7-tagged Ste2-F204S and
overexpressed untagged wild-type Ste2 (Fig. 3B) resulted in
trypsin cleavage patterns that were unaffected by a-factor for the
30 minute duration of the assay, even though the internal control
membranes containing HA-tagged wild-type receptors resulted in
trypsin cleavage patterns that were altered by the presence of a-
factor (Fig. 3C,D). These results suggest that a-factor binding to
wild-type Ste2 influences the conformational state; however,
these ligand-induced conformational changes do not affect the
conformational state of neighboring subunits in the multimeric
complex that cannot bind a-factor. In other words, subunits
within the same multimeric complex can apparently exist in
different conformational states determined by ligand occupancy.
It has been shown that Ste2-F204S is a dominant-negative
mutant that partially interferes with the functions of the wild-type
Ste2 in a dose-dependent manner (Dosil et al., 2000). Recent
evidence (Gehret et al., 2012) suggests that direct contact
between receptors contributes to the dominance phenotype.
Therefore, we considered the possibility that Ste2-F204S may
interfere with ligand-induced conformational changes in wild-
type Ste2 when the Ste2-F204S and Ste2 are co-expressed. Fig. 4
summarizes reciprocal tests for interactions between mutant and
wild-type receptors in the trypsin digestion assay. Fig. 4
compares the trypsin cleavage assays. The mutant and wild-
type receptors were defective for both N-linked glycosylation
sites. Membranes from cells expressing untagged wild-type Ste2
and T7-tagged Ste2 (Fig. 4A) and from cells expressing untagged
Ste2 and T7-tagged binding-defective mutant Ste2-F204S
(Fig. 4B) showed tryptic digestion patterns that were consistent
with the results in Fig. 3, suggesting that ligand-induced
conformational changes in wild-type receptors do not influence
the conformational state of co-expressed mutant receptors.
Membranes from cells expressing untagged Ste2-F204S
receptors and tagged receptors (Fig. 4D) resulted in ligand-
induced changes in the trypsin digestion pattern that were
indistinguishable from the results obtained with control
membranes from cells expressing only wild-type receptors
(Fig. 4A). This result indicates that Ste2-F204S does not
interfere with ligand-induced conformational changes in wild-
type Ste2.
Indirect methods have been used to investigate the molecular
basis for the dominant negative phenotype for receptor mutants
such as Ste2-F204S. Dosil et al. have found that over-production
of the three G-protein subunits reverses the dominant negative
phenotype even when the mutant receptors are more abundant
than the wild-type receptors (Dosil et al., 1998). These results
suggested that the dominant negative phenotype arises from
competition between the two receptors for a limited pool
of G proteins. In this view, the G proteins that recycle to
receptors following a-factor activation eventually accumulate in
preactivation complexes with the mutant receptor where they
cannot be released by receptor activation (Dosil et al., 2000).
More recently, Gehret et al. have found that the dominant
negative phenotype persists even when the expression of mutant
receptor is reduced to the normal level and the expression of the
wild-type receptor is reduced below the normal level (Gehret et
al., 2012). This finding would be inconsistent with the G-protein
competition model only if the G protein pool were no longer
limiting when the level of receptor expression is reduced.
Interestingly, Gehret et al. also find that the dominant negative
phenotype persists when the GPA1 coding sequence is fused to
the C-terminus of the wild-type receptor and provides the only
source of the Ga subunit (Gehret et al., 2012). This result
suggests either that the dominant negative phenotype does not
result from G protein competition or that the G proteins tethered
to the wild-type receptors can bind to mutant receptors within the
oligomeric receptor complex. Whether or not the dominant
negative phenotype of Ste2-F204S results from G-protein
competition, the results of our direct assays for receptor
conformation (Figs 4, 5) showed that wild-type receptors
undergo ligand-induced changes in the presence of mutant
receptors, suggesting that the dominant negative phenotype is a
consequence of post receptor signaling activities.
Complementation test between mutant Ste2 subunits in vivo
A functional test for cooperative interactions between a-factor
receptors in vivo was explored. We reasoned that if a-factor
binding to one receptor subunit can cause a neighboring subunit
to assume an activated conformation then a-factor responsiveness
would be restored to cells that co-express Ste2-F204S receptors
and receptors that fail to couple to the heterotrimeric G protein.
The ste2-L236H mutation affects the third intracellular loop of
the a-factor receptor. The mutant receptors are partially impaired
in signal transduction activity, but they retain ability to undergo
a-factor induced conformational changes and ability to undergo
ligand-induced endocytosis (Büküşoğlu and Jenness, 1996;
Schandel and Jenness, 1994; Weiner et al., 1993). The ste2-
F204S,T326-HA allele was used instead of STE2-F204S since it
blocks the partial dominant negative phenotype of STE2-F204S at
the level of receptor expression used (Dosil et al., 2000);
however, at lower levels of receptor expression (Gehret et al.,
2012) a truncated form of Ste2-F204S shows a dominant negative
phenotype. The ability of a-factor to cause cell division arrest
was judged by the a-factor halo test (not shown). When the
standard halo assay was used to judge a-factor-induced cell-
division arrest, the cells expressing both ste2-F204S,T326-HA
and ste2-L236H alleles were found to be no more responsive than
either of the single mutants alone, consistent with previous
observations using full-length receptor mutants (Chinault et al.,
2004). To determine whether ligand-induced changes in Ste2-
L236H are propagated to Ste2-F204S,T326-HA in a shorter-term
assay, we introduced a plasmid-borne, pheromone-inducible
gene, FUS1-LacZ, into each strain and tested for b-
galactosidase after a-factor exposure. Table 2 indicates that the
strain expressing both ste2-F204S,T326-HA and ste2-L236H
alleles was no more responsive to a-factor than the strains
expressing either of the single alleles.
Detection of conformational changes by substituted cysteine
accessibility method
Whole-cell labeling with 2-[(biotinoyl) amino] ethyl
methanethiosulfonate (MTSEA biotin) provides an independent
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assay to test whether ligand-induced conformational changes are
propagated to neighboring receptor subunits. Hauser et al. first
used MTSEA biotin labeling to show that the first extracellular
loop of Ste2 undergoes a conformational change upon a-factor
binding (Hauser et al., 2007). They showed that single cysteine
residues placed at position 101 or 106 are readily accessible to
solvent in the absence but not in the presence of a-factor. The
decrease in solvent accessibility is not due to direct steric
hindrance by the ligand since the antagonist, desTrp,Ala3-a-
factor, does not significantly alter reactivity of cysteine
residues at either position (Hauser et al., 2007). To determine
whether a-factor binding to one subunit affects the accessibility
of a cysteine residue at position 106 in an adjoining subunit,
we tested whether the HA-tagged binding-defective mutant
receptor, Ste2-Y106C, F204S-HA, undergoes a-factor-induced
conformational changes when over-produced wild-type Ste2 is
present in the same cell. In control experiments, we showed that
cysteine accessibility of the binding-proficient Ste2-Y106C-HA
receptor was sensitive to a-factor, whereas cysteine accessibility
of the Ste2-Y106C, F204S-HA was not sensitive to a-factor when
it was expressed alone (Fig. 5A). Cysteine accessibility of the
Ste2-Y106C-HA receptor remained sensitive to a-factor when
Ste2 or Ste2-F204S were over-expressed in the same cell
(Fig. 5B). However, cysteine accessibility Ste2-Y106C, F204S-
HA receptors was not influenced by a-factor when either Ste2 or
Ste2-F204S were over-expressed (Fig. 5B). These results are
consistent with the trypsin digestion assay (Figs 3, 4), indicating
that binding-defective Ste2-F204S receptors do not undergo
ligand-induced conformational changes when they are allowed to
form oligomers with wild-type Ste2 receptors. In addition, failure
of Ste2-F204S to impart a dominant-negative effect on ligand-
induced changes in Ste2-Y106C (Fig. 5, lanes 5 and 6) is
consistent with the results from the limited trypsin digestion assay
(Fig. 4), further supporting the view that the partial dominant-
negative phenotype of the STE2-F204S mutation results from G
protein competition and not from direct interaction of mutant and
wild-type receptors (Dosil et al., 2000).
DISCUSSION
This study explores functional relationships among a-factor
receptors when multireceptor complexes are endocytosed. We
found that the complexes undergo ligand-mediated endocytosis
when the a-factor binding site and the endocytosis signal
sequence are located in different receptor subunits. This result
implies that if ligand-mediated changes in the signal sequences
are required for ligand-mediated endocytosis then the
conformation associated with ligand binding must spread from
the ligand-binding protomer to other protomers containing the
endocytosis signal sequence. Both in vitro and in vivo assays
strongly suggested that ligand-induced conformational changes in
one Ste2 subunit do not affect neighboring subunits. Therefore,
the recognition of the endocytosis signal sequence and the
recognition of the ligand-induced conformational change are
likely to be two independent events. In the train passenger
metaphor, receptor protomers initiate their endocytic excursion
as a group where some of the protomers can be stimulated by
Fig. 5. Whole-cell MTSEA-labeling of receptors containing cysteine at
position 106. Cells were labeled with MTSEA in the absence (2) or
presence (+) of a-factor. Detergent solubilized receptors that had been
labeled with MTSEA were collected on avidin beads and analyzed by SDS-
PAGE and western blotting with anti-HA antiserum. (A) Strains were DJ213-
7-3 containing plasmid pDJ683 (Ste2-Y106C-HA) and strain DJ213-7-3
containing plasmid pDJ684 (Ste2-Y106C,F204S-HA). (B) Plasmids encoding
Ste2-Y106C-HA or Ste2-Y106C, F204S-HA were introduced into the strains
expressing wild type or Ste2-F204S under the direction of the GPD
transcriptional promoter. Strains were DJ484-1 containing plasmid pDJ683
(Ste2/Ste2-Y106C-HA), DJ484-1 containing plasmid pDJ684 (Ste2/Ste2-
Y106C, F204S-HA), DJ482-1 containing plasmid pDJ683 (Ste2-F204S/Ste2-
Y106C-HA), and DJ482-1 containing plasmid pDJ684 (Ste2-F204S/Ste2-
Y106C,F204S-HA). For the total protein control (lower panel), the detergent
solubilized receptors were analyzed before the avidin purification step.
Immunoblots are developed with anti-HA antiserum. Molecular weights of
markers are indicated in kDa at the left.
Table 2. Signal complementation between different subunits of
Ste2 receptors in the a-factor induced Fus1-LacZ assay
b-galactosidase activity unitsa




Ste2-L236H and Ste2-F204S-T326-HA 1.1060.02 1.1060.04
aMeasurement of b-galactosidase activity units is described in Materials and
Methods. Duplicate assays measured b-galactosidase activity in
permeabilized cells in two independent experiments. The average activity
and the standard deviation are shown.
bStrains are DJ211-5-3 containing plasmid pDJ124 and pDJ203 (Ste2),
DJ901-A-1containing plasmids pDJ124 and pDJ203 (Ste2-L236H), DJ1378-
A-1 containing plasmid pDJ691 and pDJ203 (Ste2-F204S-T326-HA) and
DJ901-A-1 containing pDJ691 and pDJ203 (Ste2-F204S-T326-HA).
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a-factor to help the others board the train, while only one
passenger needs to carry the ticket (the endocytosis signal
sequence) that is checked separately. The ability of different
receptors in the complex to provide the ligand-induced
conformational signal and the endocytosis signal sequence
predicts that multimerization-defective mutants would be
unable to cooperate in this manner. Unfortunately, we have
found that a-factor receptor mutants that fail to multimerize are
retained in the ER. Most of the mutant receptors that Overton and
Blumer found near the cell surface (Overton et al., 2003) are
probably contained in the cortical ER. We have used ER retention
as phenotype to screen for additional multimerization mutants
(Chang, 2009; C.-I.C. and D.D.J., unpublished data).
Endocytosis signals are contained within the cytoplasmic C-
terminal domain of the receptor, since truncated receptors lacking
this domain are unable to undergo both ligand-mediated and basal
endocytosis, even though these truncated receptors are proficient
in transducing the a-factor response signal. By generating a
series of truncated receptors that removed successively larger
portions of the C-terminal domain, Roher et al. identified an
endocytosis signal sequence, SINNDAKSS, located near the
seventh transmembrane segment (Rohrer et al., 1993). Covalent
modifications of the endocytosis signal appear to be essential for
its activity since endocytosis is associated with phosphorylation
and ubiquitination of SINNDAKSS (Hicke et al., 1998) and
since truncated receptors fused to the ubiquitin polypeptide are
endocytosed constitutively even when the SINNDAKSS sequence
is absent (Terrell et al., 1998). Although the signal is necessary
for endocytosis, it has been unclear whether a-factor binding
regulates its activity. Our previous results (Büküşoğlu and
Jenness, 1996) have shown that a-factor binding affects the
accessibility of trypsin to the polypeptide backbone of the
receptor near the SINNDAKSS sequence, raising the possibility
that ligand-induced changes in SINNDAKSS regulate its ability
to participate in endocytosis.
To address the ability of ligand-induced conformational changes
in one receptor to spread to neighboring protomers in the
oligomeric complex, we tested whether binding-defective
receptor mutants undergo conformational changes when they
were co-expressed with binding-proficient receptors. Three
different methods for detecting conformational change were
utilized. One method was to test for allelic complementation
between receptor mutants in vivo. Previously, no significant
complementation was observed when ligand binding- and G
protein coupling-defective mutant receptors were co-expressed
(Chinault et al., 2004). However, since ligand-binding receptor
mutants display dominant negative effects on signal transduction
(Dosil et al., 1998; Leavitt et al., 1999), we repeated this strategy
using truncated ligand-binding mutants which are not dominant.
In agreement with the previous results, we found no allelic
complementation for co-expressed ligand binding- and G protein
coupling-defective mutant receptors. As a second strategy, we
analyzed the changes in trypsin accessibility of receptors that
occur when purified plasma membranes are exposed to a-factor
(Büküşoğlu and Jenness, 1996). In plasma membranes purified
from cells co-expressing wild-type and binding-defective
receptors, we found that ligand-induced changes in trypsin
accessibility occurred only in the wild-type receptors, again
consistent with a lack of spreading of ligand-induced
conformational changes. Lastly, we took advantage of the
published observation (Hauser et al., 2007) that a-factor binding
induces changes in solvent accessibility of cysteine residues added
to the first extracellular loop of the receptor. Specifically, it was
found that mutant receptors containing cysteine residues at specific
positions in the first extracellular loop can be alkylated in the
absence but not in the presence of ligand. We found that a-factor
did not affect the alkylation of ligand-binding-defective mutant
receptors containing a conformationally sensitive cysteine residue,
even when the mutant receptors were co-expressed with wild-type
receptors. In sum, when distant conformationally sensitive sites
in the receptor were monitored (including a site near the
SINNDAKSS sequence), we found no evidence for the ability of
a-factor binding to one protomer to affect the conformational state
of neighboring protomers within the multireceptor complex.
Therefore, it is unlikely that changes in the conformation of the
endocytosis signal itself are required for ligand-induced endocytosis
of the receptor. However, we cannot exclude the possibility that
receptors within the complex are coupled by subtle ligand-induced
conformational changes, undetected by our assays.
We offer three models by which the endocytosis signal(s) may
play a role in ligand-mediated endocytosis. In one model, tight
packing of receptors within the multireceptor complex forms a
phalanx-like structure that prevents the phosphorylating and/or
ubiquitinating enzymes from gaining access to the endocytosis
signals. Ligand binding to a subpopulation of the receptors may
loosen the phalanx, permitting enzyme access and exposure of all
endocytosis signals within the complex. In the second model,
conformational changes in a subpopulation of receptors within
the complex may lead to the localization of the phosphorylating
and/or ubiquitinating enzymes to the complex. Concentrating
these enzymes at the multireceptor complex may facilitate the
modification of endocytosis signals in neighboring receptors. The
regulation of protein modification by colocalizing a modifying
enzyme with its protein substrates is common. For example, in
the a-factor signal transduction pathway, when the Ste5
scaffolding protein binds to the activated the Gbc protein, it
brings the associated Ste11 MEK kinase enzyme close to the
Ste20 kinase initiating the MAP kinase cascade (Pryciak, 2001).
Finally, in the third model, binding of ligand may lead to the
movement of the receptor complex to a subcellular compartment
(e.g. a subdomain of the plasma membrane or an early endosomal
compartment) where the complex is exposed to the modifying
enzymes. If a subpopulation of the receptors is modified then the
complex is sorted to the next endosomal compartment. If not,
the complexes recycle to the initial unspecialized domain of the
plasma membrane. This model is consistent with the slower
ligand binding kinetics of truncated receptors lacking the
endocytosis signal. Even though the equilibrium dissociation
constant is unaffected koff (and presumably kon) is markedly
slower (Schandel and Jenness, 1994), consistent with the
accumulation of receptor sites in an environment where
diffusion of the ligand is restricted.
MATERIALS AND METHODS
Plasmids and yeast strains
Strains and plasmids used in this study are listed in Table 3. Single
mutations in the STE2 gene were confirmed by DNA sequencing.
Integrating plasmid pDJ637 contains TRP1 and GPD-ste2-T58 in which
GPD (glyceraldehyde-3 phosphate dehydrogenase) promoter has been
fused to the first 58 codons from the STE2 gene. It was constructed by
ligating XhoI/SpeI fragment from pDJ432 with XhoI/SpeI cut pDJ429
containing the TRP1 gene. pDJ654 that contains the wild-type STE2 gene
fused with the sequence encoding the T7 epitope was created in two
steps. The first PCR product was obtained by using primer pair,
ATTCCAGATATGCGTTATAACCT and ACCACCAGTCATAGAA
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GCCATTTTTGATTCTTGGATATGGTT, and used plasmid pDJ135 as
a template. The second PCR product was obtained by using primer pair
ATGGCTTCTATGACTGGTGGT and GGAATTCCCAACCATGTGG
TCTGACACCAAACATAATGG, and used plasmid pDJ437 as a
template. Both PCR products were gel purified and used as template in
the final PCR reaction using primers ATTCCAGATATGCGTTATA
ACCT and GGAATTCCCAACCATGTGGTCTGACACCAAACATA
ATGG. The product was digested by MluI/HpaI and cloned into the
MluI/HpaI fragment of pDJ135. Plasmid pDJ655 contains the T7 epitope-
tagged version of STE2 with a mutation at codon 204 (F204S). PCR
primers CAATACACTTCCATATATGGGCAAGGATCTACCATCAC
TTTCGATGA and TTGCCCATATATGGAAGTGTATTGAATGGTG
CTTTGACCAGGATTATA were used to construct the plasmids pDJ656
and pDJ657 that contained either T7 epitope-tagged STE2 or STE2-
F204S gene, and both plasmids contained mutations at amino acid
position 25 and 32 (N25Q, N32Q). Two PCR products from primer pair
AGAGAAAGTAGTGACAAGTGTTG and TTACTGTCTAATTGTTC
TTCAGTGACTTACGCTC and primer pair CGGGACTAGTCATAA
AATGTCTGATGCGGCTCCTTCAT and GTAAGTCACTGAAGAAC
AATTAGACAGTAAATATTTAAAATAGAG were used with template
pDJ304 or pDJ451 for the second PCR products containing the Y106C or
Y106C, F204S codon, respectively. This product was digested with HpaI/
ClaI and cloned into plasmid pDJ304 treated with the same enzymes to
produce plasmids pDJ681 and pDJ682. Plasmids pDJ683 and pDJ684
were constructed by using a two-step PCR and cloning strategy. Plasmids
pDJ681 (containing Y106C) or pDJ682 (containing Y106C, F204S) were
used as the templates with primer pair ATTCCAGATATGCGTT
ATAACCT and CTTGGGTGGCACTAACATC to construct two PCR
products (A1 and A2), and primer pair GATGTTAGTGCCACCCAAG
and AGAGAAAGTAGTGACAAGTGTTG with template plasmid
pDJ658 were used for another PCR product (B). The A1 and B PCR
products and the A2 and B PCR products were combined and used as
template together with primer pair GCATTGAGCTCGTTATCC
AATGCCTGCCAA and CTTGGGTGGCACTAACATC to synthesize
the PCR products containing the either full-length Y106C and Y106C,
F204, respectively. These PCR products were digested with SacI/SalI and
cloned into the plasmid pDJ481 treated with the same enzymes to
produce plasmids pDJ683 and pDJ684, respectively, that carried the
LEU2 selectable marker and encoded receptors with the HA tag fused to
the C-terminus. pDJ679 was constructed by cloning the SacI/SalI DNA
fragment containing GPD-STE2,F204S from pDJ678 into pDJ481 treated
with the same enzymes. pDJ691 was constructed by cloning the MluI/
ClaI DNA fragment containing STE2-F204S from pDJ451 into pDJ469
treated with the same enzymes.
Fluorescence microscopy
Procedures for fluorescence microscopy were carried out as described
previously (Yesilaltay and Jenness, 2000) with minor modifications. Yeast
cells were grown overnight to a density of 107 cells/ml in selective medium.
Cells received cycloheximide (10 mg/ml) for 5 minutes before addition of
a-factor (1027 M). In the parallel experiment, no a-factor was added to the
culture. Cultures were incubated at 30 C̊ for 20 minutes and terminated by
the addition of the metabolic poisons, sodium azide (10 mM) and potassium
fluoride (10 mM) and chilled on ice. Cells were then collected by
centrifugation and suspended in ice-cold water. Epifluorescent images were
obtained with a Nikon microscope equipped with a Plan Apo 1006/1.40 oil
objective, a FITC-HYQ filter set and a cooled CCD camera (model ST-8I,
SBIG Astronomical Instruments, Santa Barbara, CA).
Culture media
Liquid and solid media were prepared as previously described (Hasson
et al., 1994; Jenness et al., 1997).
Table 3. Strains and plasmids
Strain Genotype
381G MATa cry1 ade-2 his4-580 lys2 trp1 tyr1 SUP4-3ts
DJ211-5-3 381G bar1-1 leu2 ura3
DJ213-7-3 381G bar1-1 leu2 ura3 ste2-10::LEU2
DJ484-1 381G bar1-1 leu2 ura3 STE2::pDJ637
DJ485-1 381G bar1-1 leu2 ura3 ste2-F204S::pDJ637
DJ901-A-1 381G bar1-1 leu2 ura3 ste2-L236H
DJ1378-A-1 381G bar1-1 leu2 ura3 ste2D
DJ213-6-3::pDJ281 381G leu2 ste2-10::LEU2 ura3::pDJ281(STE2-HA)
Plasmid Description
pDJ124 Centromeric plasmid containing LEU2 as a control vector
pDJ135 Centromeric plasmid containing URA3 and STE2
pDJ203 Centromeric plasmid containing URA3 and Fus1-lacZ
pDJ281 Integrating plasmid containing URA3 and STE2-HA
pDJ429 Integrating plasmid containing URA3 and GPD-ste2-T58
pDJ432 Integrating plasmid containing TRP1 and GPD promoter
pDJ437 Integrating plasmid containing TRP1 and GPD-ste2-T58
pDJ451 2m plasmid containing URA3 and STE2-F204S
pDJ469 Centromeric plasmid containing URA3 and ste2-T326-GFP
pDJ481 Centromeric plasmid containing LEU2 with triple HA tag
pDJ651 Centromeric plasmid containing URA3 and ste2-F204S,T326-GFP
pDJ637 Integrating plasmid containing TRP1 and GPD-ste2-T58
pDJ654 Centromeric plasmid containing URA3 and T7 epitope-tagged STE2
pDJ655 Centromeric plasmid containing URA3 and T7 epitope-taggedSTE2-F204S
pDJ656 Derived from pDJ654 with STE2-N25Q,N32Q
pDJ657 Derived from pDJ655 with STE2-F204S,N25Q,N32Q
pDJ678 Centromeric plasmid containing URA3 and GPD-ste2-F204S,T326-GFP
pDJ679 Centromeric plasmid containing LEU2 and GPD-ste2-F204S,T326-HA
pDJ681 Centromeric plasmid containing URA3 and STE2-Y106C,F204S
pDJ682 Centromeric plasmid containing LEU2 and STE2-Y106C-HA
pDJ683 Centromeric plasmid containing LEU2 and STE2-Y106C,F204S-HA
pDJ684 Centromeric plasmid containing LEU2 and GPD-STE2-HA
pDJ691 Centromeric plasmid containing LEU2 and ste2-F204S,T326-HA
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Antisera and reagents
Rabbit polyclonal antisera were specific for the carboxy-terminal portion
of Ste2 (Konopka et al., 1988). Mouse monoclonal antibody (Anti-HA-
3F10) conjugated to horseradish peroxidase (HRP) that recognizes the
influenza hemagglutinin epitope was from Roche, Mannheim, Germany.
Mouse monoclonal antibodies against T7 and conjugated to horseradish
peroxidase (HRP) were from Novagen, Madison, WI. Mixtures of mouse
monoclonal antibodies (Clones 7.1 and 13.1) that recognize green
fluorescent protein (GFP) were from Roche, Mannheim, Germany.
Peroxidase-conjugated goat anti-mouse secondary antibodies were from
Sigma Chemical Co., St Louis, MO. Antibodies were used at the
concentrations recommended by the supplier. Bovine serum albumin
(BSA), chemiluminescence kit Super Signal and UltraLink Immobilixed
Streptavidin Plus beads were from Pierce Chemical Co., Rockford, IL.
MTSEA-biotin (2-[(biotinoyl) amino] ethyl methanethiosulfonate) was
purchased from Biotium Co., Hayward, CA).
Purification of plasma membranes
Yeast cells were grown in selective medium. Membranes were then
resolved in renografin density gradients as previously described (Schandel
and Jenness, 1994), as modified below. Renografin-60 was used to replace
Renografin-76. Gradients were prepared by successively layering 2.05 ml
of 34, 30, 26, 22% renografin solutions that had been prepared by diluting
Renografin-60. Gradients were centrifuged for 20 h in an SW41 rotor at
30,000 rpm at 4 C̊. Fractions containing Pma1p were identified by
resolving the proteins by SDS PAGE and staining gels with Coomassie
Blue. Membranes from pooled fractions were collected by centrifugation
for 90 minutes in the Ti 60 rotor at 50,000 rpm at 4 C̊. Membrane pellets
were suspended in 300 ml buffer (50 mM TrisHCl, pH 7.5, 1 mM EDTA)
and dispersed with a Dounce homogenizer. Bicinchoninic acid assay
(BCA) was performed to determine the protein concentration.
Limited trypsin digestion assay
The assay was a modification of the method of Bukusoglu and Jenness
(Büküşoğlu and Jenness, 1996). Tosylsulfonyl phenylalanyl chloromethyl
ketone (TPCK) treated trypsin was from Sigma. Reaction buffer for
trypsin digestion assay contained 1 mM magnesium acetate, 0.1 mM
dithiothreitol, 0.1 mM EDTA, 7.6% glycerol and 10 mM
morpholinepropanesulfonic acid (MOPS, pH 7.0). The different time
points were from separate tubes containing aliquots (2 mg) of membrane
protein. Duplicate tubes contained a-factor (final concentration 1028 M
to 561026 M depending on the experiment). The reaction was started by
adding trypsin (final concentration 2 mg/ml). The reaction was performed
at 30 C̊ and terminated by adding 15 ml 1 N HCl. Membranes were
collected by centrifugation with the Beckman Airfuge at 28 psi for
20 minutes. Membranes were then suspended at 10 ml denaturation
buffer (0.5% sodium dodecyl sulfate (SDS) and 1% b-mercaptoethanol)
at 42 C̊ for 20 minutes. 10 ml endoglycosidase H mix was added to the
samples and incubated at 37 C̊ for 45 minutes. Proteins were denatured
with SDS sample buffer at 37 C̊ for 10 minutes and resolved on 12%
SDS-PAGE and electrophoretically transferred to a polyvinylidene
difluoride (PVDF) membrane (Millipore Corporation, Bedford, MA). The
membrane was probed with horseradish peroxidase (HRP) conjugated
monoclonal antibody against the T7 or the HA epitope and visualized by
using the chemiluminescence kit (Pierce Chemical Co., Rockford, IL).
Trypsin digestion assays using plasma membranes from cells expressing the
glycosylation-defective mutant receptors were performed in a same way
except that the endoglycosidase H digestion steps were omitted. At the end
of the reaction, membranes were collected by centrifugation, suspended
directly in the SDS sample and loaded onto SDS-PAGE.
Fus1-LacZ b-galactosidase assay
Yeast cells were grown to exponential phase overnight in selective
medium. Density of the culture was estimated spectrophotometrically.
Cultures were diluted to the 107 cells/ml, and 1 ml of cell suspension was
treated with and without a-factor 1028 M for 2 hours at 30 C̊. Each
reaction was performed in duplicate. Inductions were terminated by
addition of 10 ml 10 mg/ml cycloheximide. Cells were collected by
centrifugation, and pelleted cells were suspended in 4 ml Z buffer
(10 mM potassium chloride, 1 mM magnesium sulfate, 0.1 M sodium
phosphate, pH 7). 1.5 ml cell suspension was added to 750 ml ZSB buffer
(Z buffer with 50 mM b-mercaptoethanol and 0.01% SDS). Cells were
permeabilized by adding 60 ml chloroform and vortexing vigorously.
200 ml of 4 mg/ml colorimetric substrate, o-nitrophenol-b-
galactopyranoside, was added to the permeabilized cells and incubated
at 28 C̊ for 30 minutes. Reactions were terminated by adding 500 ml 1 M
sodium carbonate. Cell debris was removed by centrifugation at
2,000 rpm for 10 minutes. The supernatant was transferred to a new
tube to measure A420. Units of activity were calculated by using the
formula of (10006A420 of reaction)4(A600 of culture6volume [in ml] of
culture used6time of reaction [in min]). Units of activity were
(A42061000)4(A60061.5 ml630 min)5A420622.24A600.
MTSEA-labeling, immobilization, membrane preparation and
immunoblots
Whole-cell MTSEA-labeling in this study was performed essentially as
described (Hauser et al., 2007) and is summarized in brief. Plasmids
encoding constructs STE2-Y106C-HA and STE2-Y106C,F204S-HA were
transformed into yeast strains DJ213-7-3, DJ484-1 and DJ485-1. The
chromosomal STE2 locus in yeast strains DJ484-1 and DJ485-1 was under
the control of the constitutive GPD promoter. Cells were cultured in
selective media overnight at 30 C̊ (strain DJ213-7-3) or 34 C̊ (strains
DJ484-1 and DJ485-1). Cells were harvested at mid-log phase and
processed for MTSEA biotin labeling in the presence and absence of a-
factor (Hauser et al., 2007). MTSEA-biotin treated cells were lysed by
vortexing with glass beads. A low speed supernatant fraction (700 6 g,
5 min) was prepared, and the membranes were pelleted (15,000 6 g,
30 min). Protein concentration was determined using the Bio-Rad Protein
assay (Bio-Rad Laboratories, Hercules, CA). Membranes were solubilized
in RIPA buffer (0.1% SDS, 1% Triton X-100, 0.5% deoxycholic acid,
1 mM EDTA in 16 PBS, pH 7.4), cleared with a high-speed spin
(15,0006g, 15 min), and adsorbed to UltraLink Immobilixed Streptavidin
Plus beads (Pierce, Rockford, IL). The beads were washed extensively,
extracted with SDS sample buffer (10% glycerol, 1% SDS, 0.03%
bromophenol blue, 62.5 mM TrisHCl, pH 6.8, 5% 2-mercaptoethanol) at
55 C̊, resolved by 10% acrylamide SDS-PAGE and transferred to
Immobilon2 membrane (Millipore Corporation, Bedford, MA). The blot
was then probed with anti-HA antibodies. The receptors were detected by
developing the blot with the West Pico chemiluminescent detection system
(Pierce Biotechnology, Inc., Rockford, IL).
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